drugset / Trial / NCT02219633

Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

NCT02219633 ↗

Phase 1 Completed 30 enrolled LEO Pharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this trial is to assess the efficacy of LEO 39652 cream compared with LEO 39652 cream vehicle in adults with mild to moderate AD after 3 weeks of treatment.

Timeline

Start
2014-07
Primary completion
2014-12
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject LEO 39652 Unknown — Topical

Indications